Back to Search
Start Over
Researcher from Saitama Cancer Center Details New Studies and Findings in the Area of Multiple Myeloma (ctDNA improves prognostic prediction in relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone)
- Source :
- Obesity, Fitness & Wellness Week. March 23, 2024, 4734
- Publication Year :
- 2024
-
Abstract
- 2024 MAR 23 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on multiple myeloma have been presented. According to news reporting [...]
- Subjects :
- Diagnosis
Care and treatment
Prevention
Prognosis
Risk factors
Dosage and administration
Health aspects
Recurrence (Disease) -- Risk factors -- Prevention
Gene mutation -- Health aspects
Multiple myeloma -- Diagnosis -- Care and treatment -- Prognosis
Proteasome inhibitors -- Dosage and administration
Gene mutations -- Health aspects
Diseases -- Relapse
Subjects
Details
- Language :
- English
- ISSN :
- 15316386
- Database :
- Gale General OneFile
- Journal :
- Obesity, Fitness & Wellness Week
- Publication Type :
- Periodical
- Accession number :
- edsgcl.786697848